Terms: = Ovarian cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616 AND Treatment
25 results:
1. ovarian high-grade serous carcinoma cells with low smarca4 expression and high SMARCA2 expression contribute to platinum resistance.
Kido K; Nojima S; Motooka D; Nomura Y; Kohara M; Sato K; Ohshima K; Tahara S; Kurashige M; Umeda D; Takashima T; Kiyokawa H; Ukon K; Matsui T; Okuzaki D; Morii E
J Pathol; 2023 May; 260(1):56-70. PubMed ID: 36763038
[TBL] [Abstract] [Full Text] [Related]
2. The Emerging Role of Chromatin Remodeling Complexes in ovarian cancer.
Vaicekauskaitė I; Sabaliauskaitė R; Lazutka JR; Jarmalaitė S
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430148
[TBL] [Abstract] [Full Text] [Related]
3. Small Cell Carcinoma of Ovary, Hypercalcemic Type: A Rare Case Report.
Coşkun Ç; Kurucu N; Usubutun A; Soyer T; Ozcan HN; Çelik Ertaş NB; Kutluk T
J Pediatr Adolesc Gynecol; 2023 Apr; 36(2):112-115. PubMed ID: 36243275
[TBL] [Abstract] [Full Text] [Related]
4. OTUD6A promotes prostate tumorigenesis via deubiquitinating brg1 and AR.
Fu X; Zhao J; Yu G; Zhang X; Sun J; Li L; Yin J; Niu Y; Ren S; Zhu Y; Xu B; Huang L
Commun Biol; 2022 Mar; 5(1):182. PubMed ID: 35233061
[TBL] [Abstract] [Full Text] [Related]
5. Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (ovarian Rhabdoid Tumor) with
Simões MFE; da Costa AABA; Silva TN; Fernandes L; Bovolim G; Torrezan GT; Carraro DM; Baiocchi G; Menezes ANO; Santana Dos Santos E; De Brot L
Curr Oncol; 2022 Jan; 29(2):411-422. PubMed ID: 35200537
[TBL] [Abstract] [Full Text] [Related]
6. ovarian carcinoma in children with constitutional mutation of smarca4: single-family report and literature review.
Pastorczak A; Krajewska K; Urbanska Z; Szmyd B; Salacinska-Los E; Kobos J; Mlynarski W; Trelinska J
Fam Cancer; 2021 Oct; 20(4):355-362. PubMed ID: 33907931
[TBL] [Abstract] [Full Text] [Related]
7. FOXO1 mitigates the SMAD3/FOXL2
Secchi C; Benaglio P; Mulas F; Belli M; Stupack D; Shimasaki S
J Transl Med; 2021 Feb; 19(1):90. PubMed ID: 33639972
[TBL] [Abstract] [Full Text] [Related]
8. Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase Inhibition.
Shorstova T; Su J; Zhao T; Dahabieh M; Leibovitch M; De Sa Tavares Russo M; Avizonis D; Rajkumar S; Watson IR; Del Rincón SV; Miller WH; Foulkes WD; Witcher M
Mol Cancer Ther; 2021 Jan; 20(1):64-75. PubMed ID: 33087508
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological significance of multiple molecular features in undifferentiated and dedifferentiated endometrial carcinomas.
Zhang K; Liu Y; Liu X; Du J; Wang Y; Yang J; Li Y; Liu C
Pathology; 2021 Feb; 53(2):179-186. PubMed ID: 33070954
[TBL] [Abstract] [Full Text] [Related]
10. Small Cell Carcinoma of the Ovary: Clinicopathologic and Immunohistochemical Analysis of 7 New Cases of a Rare Malignancy.
Gupta P; Kapatia G; Gupta N; Dey P; Rohilla M; Gupta A; Rai B; Suri V; Rajwanshi A; Srinivasan R
Int J Surg Pathol; 2021 May; 29(3):236-245. PubMed ID: 32772748
[TBL] [Abstract] [Full Text] [Related]
11. Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links.
Rickman KA; Noonan RJ; Lach FP; Sridhar S; Wang AT; Abhyankar A; Huang A; Kelly M; Auerbach AD; Smogorzewska A
Genes Dev; 2020 Jun; 34(11-12):832-846. PubMed ID: 32354836
[TBL] [Abstract] [Full Text] [Related]
12. Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New treatment Targets, and Current Management Guidelines.
Tischkowitz M; Huang S; Banerjee S; Hague J; Hendricks WPD; Huntsman DG; Lang JD; Orlando KA; Oza AM; Pautier P; Ray-Coquard I; Trent JM; Witcher M; Witkowski L; McCluggage WG; Levine DA; Foulkes WD; Weissman BE
Clin Cancer Res; 2020 Aug; 26(15):3908-3917. PubMed ID: 32156746
[TBL] [Abstract] [Full Text] [Related]
13. Germline mutations of smarca4 in small cell carcinoma of the ovary, hypercalcemic type and in smarca4-deficient undifferentiated uterine sarcoma: Clinical features of a single family and comparison of large cohorts.
Connor YD; Miao D; Lin DI; Hayne C; Howitt BE; Dalrymple JL; DeLeonardis KR; Hacker MR; Esselen KM; Shea M
Gynecol Oncol; 2020 Apr; 157(1):106-114. PubMed ID: 31954538
[TBL] [Abstract] [Full Text] [Related]
14. [Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].
Höhn AK; Brambs CE; Opitz S; Erber R; Hartmann A; Horn LC
Pathologe; 2019 Nov; 40(6):609-618. PubMed ID: 31578630
[TBL] [Abstract] [Full Text] [Related]
15. Gynecological neoplasms associated with paraneoplastic hypercalcemia.
Lim D; Oliva E
Semin Diagn Pathol; 2019 Jul; 36(4):246-259. PubMed ID: 30772079
[TBL] [Abstract] [Full Text] [Related]
16. Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type.
Wang Y; Chen SY; Colborne S; Lambert G; Shin CY; Santos ND; Orlando KA; Lang JD; Hendricks WPD; Bally MB; Karnezis AN; Hass R; Underhill TM; Morin GB; Trent JM; Weissman BE; Huntsman DG
Mol Cancer Ther; 2018 Dec; 17(12):2767-2779. PubMed ID: 30232145
[TBL] [Abstract] [Full Text] [Related]
17. Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade.
Jelinic P; Ricca J; Van Oudenhove E; Olvera N; Merghoub T; Levine DA; Zamarin D
J Natl Cancer Inst; 2018 Jul; 110(7):787-790. PubMed ID: 29365144
[TBL] [Abstract] [Full Text] [Related]
18. Comprehensive genomic profiling reveals inactivating smarca4 mutations and low tumor mutational burden in small cell carcinoma of the ovary, hypercalcemic-type.
Lin DI; Chudnovsky Y; Duggan B; Zajchowski D; Greenbowe J; Ross JS; Gay LM; Ali SM; Elvin JA
Gynecol Oncol; 2017 Dec; 147(3):626-633. PubMed ID: 29102090
[TBL] [Abstract] [Full Text] [Related]
19. Rare non-epithelial ovarian neoplasms: Pathology, genetics and treatment.
Foulkes WD; Gore M; McCluggage WG
Gynecol Oncol; 2016 Jul; 142(1):190-198. PubMed ID: 27079213
[TBL] [Abstract] [Full Text] [Related]
20. The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type.
Witkowski L; Goudie C; Ramos P; Boshari T; Brunet JS; Karnezis AN; Longy M; Knost JA; Saloustros E; McCluggage WG; Stewart CJR; Hendricks WPD; Cunliffe H; Huntsman DG; Pautier P; Levine DA; Trent JM; Berchuck A; Hasselblatt M; Foulkes WD
Gynecol Oncol; 2016 Jun; 141(3):454-460. PubMed ID: 26975901
[TBL] [Abstract] [Full Text] [Related]
[Next]